Evaggelos Dedepsidis, Vaia Pliaka, Zaharoula Kyriakopoulou, Christos Brakoulias, Stamatina Levidiotou-Stefanou, Anastassia Pratti, Zissis Mamuris, Panayotis Markoulatos
Department of Biochemistry and Biotechnology, University of Thessaly, Greece.
FEMS immunology and medical microbiology 2008 AprThe genetic properties of strain K/2002, isolated from fecal samples of a 7-month-old child who had received his first oral poliovirus vaccine (OPV) dose at the age of 3 months, are described. Preliminary sequencing characterization of isolate K/2002 revealed an S3/S2 recombination event at the 3' end of the VP1 coding region. A recombination event resulted in the introduction of six Sabin 2 amino acid residues in a Sabin 3 genomic background. Furthermore, mutations associated with loss of the attenuated phenotype of Sabin 3 strains have been identified in the genome of isolate K/2002. The data presented here emphasize the need for careful planning of vaccination strategies, which involve stopping OPV administration in regions that are certified to be polio-free.
Evaggelos Dedepsidis, Vaia Pliaka, Zaharoula Kyriakopoulou, Christos Brakoulias, Stamatina Levidiotou-Stefanou, Anastassia Pratti, Zissis Mamuris, Panayotis Markoulatos. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant. FEMS immunology and medical microbiology. 2008 Apr;52(3):343-51
PMID: 18328076
View Full Text